It demonstrated that cerebrosides could attenuate excessive tau protein phosphorylation by modulating the PI3K/Akt/GSK-3β signaling pathway, thereby exhibiting significant neuroprotective potential in the context of Alzheimer’s disease. The gene discussed is MAPT; the disease is Alzheimer disease.